Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

IBIS-II investigators

Research output: Contribution to journalArticlepeer-review

459 Citations (Scopus)
411 Downloads (Pure)

Search results